All Galveston National Laboratory articles
-
NewsScientists track breakthrough single-dose vaccines for Andes hantavirus strain
Researchers report the development of new vaccines that, in animal testing, provided full protection against the deadly Andes hantavirus after a single dose. They are working to fast-track these single-dose vaccines into human clinical trials.
-
NewsResearch uncovers possible monoclonal antibody treatment for Lassa fever
New research potentially points to an effective treatment for Lassa fever, a dangerous, often fatal disease common to much of West Africa but considered a major threat to global health.